Opaleye Management INC Lowered Its Position in Axogen INC (AXGN) by $3.80 Million

AxoGen, Inc. (NASDAQ:AXGN) Logo

Opaleye Management Inc decreased its stake in Axogen Inc (AXGN) by 18.18% based on its latest 2019Q2 regulatory filing with the SEC. Opaleye Management Inc sold 200,000 shares as the company’s stock declined 24.93% . The hedge fund held 900,000 shares of the health care company at the end of 2019Q2, valued at $17.82M, down from 1.10M at the end of the previous reported quarter. Opaleye Management Inc who had been investing in Axogen Inc for a number of months, seems to be less bullish one the $563.31 million market cap company. The stock increased 0.42% or $0.06 during the last trading session, reaching $14.35. About 304,294 shares traded. AxoGen, Inc. (NASDAQ:AXGN) has declined 60.31% since September 13, 2018 and is downtrending. It has underperformed by 60.31% the S&P500.

Opaleye Management Inc, which manages about $151.96 million and $328.09 million US Long portfolio, upped its stake in Odonate Therapeutics Inc by 100,000 shares to 425,000 shares, valued at $15.59M in 2019Q2, according to the filing.

Analysts await AxoGen, Inc. (NASDAQ:AXGN) to report earnings on November, 4. They expect $-0.17 earnings per share, down 54.55 % or $0.06 from last year’s $-0.11 per share. After $-0.16 actual earnings per share reported by AxoGen, Inc. for the previous quarter, Wall Street now forecasts 6.25 % negative EPS growth.

More notable recent AxoGen, Inc. (NASDAQ:AXGN) news were published by: Seekingalpha.com which released: “AxoGen Q2 2019 Earnings Preview – Seeking Alpha” on August 05, 2019, also Globenewswire.com with their article: “AxoGen, Inc. Pre-Announces Financial and Operational Results – GlobeNewswire” published on January 07, 2019, Globenewswire.com published: “AxoGen to Participate at AAHS ASPN ASRM 2019 Annual Meetings – GlobeNewswire” on January 24, 2019. More interesting news about AxoGen, Inc. (NASDAQ:AXGN) were released by: Globenewswire.com and their article: “Axogen, Inc. to Participate at Upcoming Investor Conferences – GlobeNewswire” published on May 23, 2019 as well as Globenewswire.com‘s news article titled: “Axogen Announces Publication of the 100th Peer-Reviewed Clinical Paper Featuring its Product Portfolio for Peripheral Nerve Repair – GlobeNewswire” with publication date: July 26, 2019.

AxoGen, Inc. (NASDAQ:AXGN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.